Suchergebnisse - "COVID-19 treatment"

PubPharm (330)

31

Severe COVID-19 : Drugs and Clinical Trials

enthalten in: Journal of clinical medicine | 2023

von Ceja-Gálvez, H. | Renteria-Flores, F. | Nicoletti, F. | +3

32

Drug-Induced Acute Pancreatitis in Hospitalized COVID-19 Patients

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Paramythiotis, D. | Karlafti, E. | Veroplidou, K. | +5

33

A Prospective Cohort Study of COVID-19 : Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Al Kharusi, M. | Al Sheikh, N. | Alhajri, M. | +5

34

Donor selection for adoptive cell therapy with CD45RA- memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release

enthalten in: Cytotherapy | 2023

von Al-Akioui-Sanz, K. | Pascual-Miguel, B. | Díaz-Almirón, M. | +11

35

Clinical Outcomes After Use of Inhaled Corticosteroids or Oral Steroids in a COVID-19 Telemedicine Clinic Cohort : Retrospective Chart Review

enthalten in: JMIR formative research | 2023

von Cellai, M. | Roberts, J. | Moore, M. | +1

36

Prevention and treatment of COVID-19 infection by earthing

enthalten in: Biomedical journal | 2023

von Mousa, H.

37

Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital : A Contribution to a Still Inadequate Body of Evidence

enthalten in: Children (Basel, Switzerland) | 2023

von Arrieta, A. | Galvis, A. | Osborne, S. | +9

38

Non-anticoagulant heparin derivatives for COVID-19 treatment

enthalten in: International journal of biological macromolecules | 2023

von Cao, M. | Qiao, M. | Sohail, M. | +1

39

Hamburg Edoxaban foR anticoagulation in COvid-19 study : Hamburg Edoxaban foR anticoagulation in COvid-19 study - HERO-19

enthalten in: WHO International Clinical Trials Registry Platform | 2023

40

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People with Weakened Immune Systems or at Increased Risk for Poor Outcomes who are Hospitalized Due to Severe COVID-19 : AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE BLIND, 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID-19 IN HOSPITALIZED PARTICIPANTS WHO ARE IMMUNOCOMPROMISED OR AT INCREASED RISK FOR SEVERE COVID-19 OUTCOMES

enthalten in: WHO International Clinical Trials Registry Platform | 2023